OrbiMed Royalty Opportunities II, LP — Form D

OrbiMed Royalty Opportunities II, LP of NEW YORK, NY, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2015-02-02. The offering totals $900.0M, of which $900.0M was reported sold. Industry: Pooled Investment Fund.

Offering

• Filed: 2015-02-02
• Form: D
• Accession: 0001632107-15-000001
• Industry: Pooled Investment Fund
• Exemptions: 06b, 3C, 3C.7
• Total offering: $900.0M
• Amount sold: $900.0M
• Minimum investment: $750K
• Investors: 83
• Date of first sale: 2015-01-30
• Security types: fund interests
• Revenue range: Not Applicable
• SEC file number: 021-233267

Issuer

• Name: OrbiMed Royalty Opportunities II, LP
• CIK: 0001632107
• Entity type: Limited Partnership
• Jurisdiction: DELAWARE
• Incorporated: 2015
• Address: 601 LEXINGTON AVENUE, 54TH FLOOR, NEW YORK, NY, 10022
• Phone: 212-739-6400

Officers, directors & promoters (9)

More

• CIK 1632107 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search